To test the predictive potential of the CuRGscores in the clinical setting, we determined the relationship between the anti-PD-1/PD-L1 immunotherapeutic response and CuRGscore in the GSE78220 dataset with pre-treatment melanomas undergoing anti-PD-1 therapy (Hugo et al., 2016). This evidence concerns the gene PDCD1 and melanoma.